See Tai Sandi - Insider Non-Derivative Transactions at Lexeo Therapeutics, Inc. (LXEO) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 18, 2025, See Tai Sandi's relationship to Lexeo Therapeutics, Inc. (LXEO) is Officer (Chief Development Officer), and currently has 65,476 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other LXEO insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

See Tai Sandi - Insider Non-Derivative Transactions of LXEO Common Stock

See Tai Sandi - Insider Non-Derivative Transactions at LXEO

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 19, 2025	Sell -- (Common Stock)	386	9.27	65476
Oct 18, 2025	Sell -- (Common Stock)	44	9.56	65862
Oct 18, 2025	Sell -- (Common Stock)	3844	8.94	65906
Oct 16, 2025	Acquisition -- (Common Stock)	10890	0	69750
Aug 19, 2025	Sell -- (Common Stock)	382	4.67	58860
May 17, 2025	Sell -- (Common Stock)	367	2.77	59242
Mar 15, 2025	Acquisition -- (Common Stock)	5720	2.61	59609
Feb 20, 2025	Sell -- (Common Stock)	1486	4.41	53889
Jan 8, 2025	Acquisition -- (Common Stock)	38750	0	55375